What is translational medicine?

It is a branch of medical research that attempts to create a more direct link between basic research and clinical care. The importance of translational medicine in the health industry continues to grow, and its precise definition continues to evolve. In the context of drug development, translational medicine typically means taking the results of basic research and turning them into real treatments for real patients, emphasizing the connection from the lab to the bedside, which is often referred to as the "bench-to-bedside" definition.

Translational medicine also has a broader meaning, which refers to the development and application of new technologies from the patient's point of view, emphasizing early detection of patients and early assessment of disease. In modern medicine, we are seeing the research process move in a more open, patient-centered direction, as well as an accommodation of the clinical practice of medicine from research.

Traditionally, basic research and clinical practice have been separated by a series of barriers, which act as "fence walls". New drugs are developed in the lab in isolation from the clinic, and are inevitably "thrown over the fence" when safety testing and clinical trials are required. Many pharmaceutical companies are establishing translational medicine teams to improve communication between basic research and clinical medicine.

From the above definition, we can see that translational medicine advocates a patient-centered approach, identifying and proposing problems from clinical work, conducting in-depth research by basic researchers, and then rapidly transferring the results of the basic research to clinical applications, with close cooperation between basic and clinical scientists to improve the overall level of medical care. Therefore, the conversion of medical research advocates breaking the previous research group single discipline or limited cooperation mode, emphasizing the multidisciplinary composition of the subject of the attack group, to play their respective strengths, full cooperation.

For example, the research on biomarkers, a new parameter for diagnosing and monitoring human diseases, is composed of researchers specializing in basic medicine, clinical medicine and bioinformatics***, who regularly discuss and communicate with each other to solve problems encountered in the research process in a timely manner, which not only opens up a revolutionary new way of developing new medicines and researching new therapeutic methods, but also brings a new way of researching and developing new medicines. This not only opens up a new way with revolutionary significance for the development of new drugs and research on new treatments, but also helps to explore new treatments and shorten the time from experimental to clinical stages of new treatments, which in turn rapidly improves the quality of medical care and treatment work.

We believe that medical devices should be included in the above definition of "new drugs", and that a more reasonable expression would be "new medical products". This not only involves the development of new medical devices, but also medical devices such as imaging equipment, which may play an important role in the development of new medical products.